TWI710381B - 經皮吸收製劑 - Google Patents

經皮吸收製劑 Download PDF

Info

Publication number
TWI710381B
TWI710381B TW106103164A TW106103164A TWI710381B TW I710381 B TWI710381 B TW I710381B TW 106103164 A TW106103164 A TW 106103164A TW 106103164 A TW106103164 A TW 106103164A TW I710381 B TWI710381 B TW I710381B
Authority
TW
Taiwan
Prior art keywords
drug storage
storage layer
adhesive
transdermal absorption
drug
Prior art date
Application number
TW106103164A
Other languages
English (en)
Chinese (zh)
Other versions
TW201726119A (zh
Inventor
天野智史
竹內昭雄
小林弘明
黑川隆夫
山﨑真美子
栗林満
本村啟太
Original Assignee
日商久光製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商久光製藥股份有限公司 filed Critical 日商久光製藥股份有限公司
Publication of TW201726119A publication Critical patent/TW201726119A/zh
Application granted granted Critical
Publication of TWI710381B publication Critical patent/TWI710381B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW106103164A 2016-01-28 2017-01-26 經皮吸收製劑 TWI710381B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP??2016-014170 2016-01-28
JP2016014170 2016-01-28

Publications (2)

Publication Number Publication Date
TW201726119A TW201726119A (zh) 2017-08-01
TWI710381B true TWI710381B (zh) 2020-11-21

Family

ID=59398365

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106103164A TWI710381B (zh) 2016-01-28 2017-01-26 經皮吸收製劑

Country Status (3)

Country Link
JP (1) JP6556873B2 (fr)
TW (1) TWI710381B (fr)
WO (1) WO2017131034A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3558276A1 (fr) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Système thérapeutique transdermique contenant de l'asénapine et un polysiloxane ou un polyisobutylène
MX2019007391A (es) 2016-12-20 2019-08-16 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.
WO2019002204A1 (fr) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Système thérapeutique transdermique contenant de l'asénapine et un polymère hybride acrylique de type silicone
WO2019243452A1 (fr) 2018-06-20 2019-12-26 Lts Lohmann Therapie-Systeme Ag Système thérapeutique transdermique contenant de l'asénapine
CN112789039B (zh) 2018-10-01 2023-10-24 久光制药株式会社 含有阿塞那平的贴剂
CN113226308A (zh) 2018-10-01 2021-08-06 久光制药株式会社 含有阿塞那平的贴剂
CN112823793A (zh) * 2019-11-20 2021-05-21 成都康弘药业集团股份有限公司 一种含有多奈哌齐的透皮贴剂及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124462A (ja) * 1995-11-01 1997-05-13 Nitto Denko Corp 貼付剤および貼付製剤
CN102316901A (zh) * 2009-02-18 2012-01-11 久光制药株式会社 经皮吸收制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07157423A (ja) * 1993-12-06 1995-06-20 Sekisui Chem Co Ltd 経皮吸収貼付剤
IT1294748B1 (it) * 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
EP1992363B1 (fr) * 2006-02-28 2012-12-19 Hisamitsu Pharmaceutical Co., Inc. Preparation pour absorption transdermique
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124462A (ja) * 1995-11-01 1997-05-13 Nitto Denko Corp 貼付剤および貼付製剤
CN102316901A (zh) * 2009-02-18 2012-01-11 久光制药株式会社 经皮吸收制剂

Also Published As

Publication number Publication date
JPWO2017131034A1 (ja) 2018-09-06
WO2017131034A1 (fr) 2017-08-03
TW201726119A (zh) 2017-08-01
JP6556873B2 (ja) 2019-08-07

Similar Documents

Publication Publication Date Title
TWI710381B (zh) 經皮吸收製劑
JP3489831B2 (ja) 活性成分パッチ
US6316022B1 (en) Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US5306503A (en) Patch with a high content of softening ingredients
JP3523259B2 (ja) 溶媒なしに製造できる揮発性活性物質を含有するプラスター
EP1696013B1 (fr) Adhésif autocollant et pastille
US20070264319A1 (en) Transdermal Antiemesis Delivery System, Method and Composition Therefor
JP5615697B2 (ja) β遮断剤の安定化組成物およびそれを用いた経皮吸収製剤
KR101853082B1 (ko) 활성제층 및 활성제 변환층을 포함하는 경피 조성물
JP4824963B2 (ja) 貼付材及び貼付製剤
JP5542791B2 (ja) 経皮吸収製剤
JP6360614B2 (ja) 貼付剤
RU2504363C2 (ru) Усилитель чрескожного всасывания и трансдермальный препарат с его использованием
JP6457486B2 (ja) 貼付製剤
WO2014111790A2 (fr) Système d'administration de médicament pharmaceutique transdermique stable comprenant de la rivastigmine
JP2003534365A (ja) 非吸蔵性裏打ち層を有する吸蔵性経皮治療系
WO2020158879A1 (fr) Timbre adhésif
US20050186262A1 (en) Transdermal delivery device for dihydropyridine type calcium antagonists
WO2023025195A1 (fr) Patch transdermique d'apixaban et son procédé de préparation
JP3980634B2 (ja) 活性物質モルフィン−６−グルクロニドを含む全身的経皮投与用医薬組成物
KR101353478B1 (ko) 펜타닐을 함유하는 경피투여용 패취 제제
US7323191B2 (en) Transdermal warfarin system
KR19980027318A (ko) 비스테로이드성 소염진통제를 함유하는 경피흡수제제와 그의 제조방법
JP2019034905A (ja) デヒドロ酢酸含有経皮吸収製剤